This is a $22,755 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services based in South San Francisco, California. The contract is for the provision of Mission Bio's Tapestri Single-Cell DNA and Protein Reagent Kits, sequencing instruments, and genomic analysis services to support critical biomedical research efforts in areas such as infectious disease,...
The U.S. National Institutes of Health (NIH) awarded a $21,230.00 firm fixed price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for Mission Bio's Tapestri Single Cell DNA and Protein Kit, which supports NIH's biomedical research and genomics efforts in areas like infectious disease, hematology, oncology, and personalized medicine. Mission Bio is a registered federal contractor that has previously received NIH...
The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order contract to Mission Bio, Inc., a for-profit manufacturer, to provide a Tapestri Single-Cell DNA Training Kit. The contract has a potential value of $162,150.00 and a completion date of January 19, 2024. This award does not have a small business set-aside designation. Mission Bio is a vendor that has previously received prime federal contract awards and...
This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) to Mission Bio, Inc., a for-profit manufacturer of biological supplies, reagent kits, sequencing instruments, and sequencing services. The $21,230 contract supports NIH's biomedical research and genomics efforts in areas such as infectious disease, hematology, oncology, and personalized medicine. Mission Bio has also received a $1.8 million National Cancer Institute grant to support measurable residual...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $134,160 purchase order to Mission Bio, Inc. of South San Francisco, California. The firm fixed price order is for Mission Bio Tapestri reagents and services to support the agency's biomedical research efforts. No major subcontractors or set aside designations were indicated. Mission Bio will provide its Tapestri single-cell DNA and RNA sequencing platform reagents from June 2023 through August...
This is a $67,980 firm fixed price purchase order awarded by the National Heart, Lung and Blood Institute (NHLBI) to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing instruments and services. The contract is for a project titled "Clonal Evolution of Driver Mutations in Patients" and has an ultimate completion date of September 9, 2025. The award does not have a set-aside designation. Mission Bio, a company registered in the System for Award...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $34,966 firm fixed-price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for the delivery of Tapestri Single-Cell DNA + Protein Reagent Kits to support NHLBI's biomedical research and genomics efforts. The contract has a performance period through December 19, 2025 and does not utilize any...
The federal contract award is a firm fixed-price purchase order valued at $138,625 issued by the National Institutes of Health National Institute on Aging to Mission Bio, Inc. for the delivery of a Tapestri Multiome Sequencing Instrument. The instrument will support the agency's research efforts to sequence multiple types of biological data from a single sample. The contract has a period of performance from June 20th, 2023 through September 20th, 2023 with delivery to occur within 30 days of...
Mission Bio, Inc. has been awarded a firm fixed price purchase order valued at one hundred sixty-six thousand seven hundred twenty-nine dollars by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH). The contract is for a project titled "Clonal Evolution of Driver Mutations" to be performed in South San Francisco, California over a one year period concluding in August 2024. As part of the NIH's efforts to advance understanding of the...
Mission Bio, Inc. was awarded a $39,880 purchase order by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to deliver single-cell DNA protein reagent kits. The firm-fixed price order is for a one-year base period of performance beginning September 15, 2023 through September 14, 2024 in South San Francisco, California. The original solicitation sought single-cell DNA and protein reagent kits to support NHLBI's research efforts...